Clinical Trials Insight: 700020217
Latest Information Update: 26 Jun 2008
At a glance
- Drugs MVA BN HER2 (Primary) ; Antineoplastics
 - Indications Breast cancer
 - Focus Adverse reactions; Therapeutic Use
 - Sponsors Bavarian Nordic
 
Most Recent Events
- 19 Jun 2008 Interim results reported in a Bavarian Nordic media release (9090334).
 - 29 Apr 2008 Enrolment is continuing as planned, according to a Bavarian Nordic media release.
 - 29 Apr 2008 Results data is expected in quarter 2 2008, according to a Bavarian Nordic media release.